Lexicon Pharmaceuticals (LXRX) Stock Research

Lexicon Pharmaceuticals

· LXRX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

809.82 M

-4.40%

Today

Lexicon management to meet with Cantor

LXRX

4:25 PM

Lexicon management to meet with Cantor

LXRX

4:09 PM

Over a week ago

Midday Fly By: Nvidia boosts buyback, Boeing discovers 737 Max glitch

+27

Sep 28, 11:59 AM

Lexicon initiated with bullish view at Cantor Fitzgerald, here's why

LXRX

Sep 28, 8:04 AM

Lexicon initiated with bullish view at Cantor Fitzgerald

LXRX

Sep 28, 6:29 AM

Lexicon announces results from post hoc analysis of SOLOIST-WHF trial

LXRX

Aug 31, 8:53 AM

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Aug 24, 8:44 AM

Lexicon registers to sell 1.26M shares of common stock for holders

LXRX

Aug 6, 5:09 PM

Lexicon reports Q2 EPS (7c), consensus (5c)

LXRX

Aug 6, 9:03 AM

Lexicon completes enrollment in SONATA-HCM study

LXRX

Jul 27, 9:12 AM

Lexicon price target raised by 80c at Citi

LXRX

May 11, 6:46 AM

Lexicon reports Q1 EPS 0c, consensus (4c)

LXRX

May 7, 9:19 AM

Lexicon to present data at AAN annual meeting on Progress Phase 2b study

LXRX

Apr 17, 8:15 AM

Lexicon COGT reports Q1 EPS $2.07, consensus $1.74

LXRX

Apr 17, 8:07 AM

Lexicon, Novo Nordisk announce initiation of LX9851 study

Mar 23, 7:40 AM

Lexicon announces results from post hoc analysis on data of sotagliflozin

LXRX

Mar 11, 8:12 AM

Lexicon price target raised by 20c at Citi

LXRX

Mar 10, 6:46 AM

Lexicon price target raised by $2 at H.C. Wainwright, here's why

LXRX

Mar 5, 11:02 AM

Lexicon reports Q4 EPS (4c), consensus (7c)

LXRX

Mar 5, 7:04 AM

Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat

+27

Jan 30, 11:57 AM

Lexicon 32M share Spot Secondary priced at $1.30

LXRX

Jan 30, 6:04 AM

Lexicon announces common stock offering, no amount given

LXRX

Jan 29, 4:32 PM

What You Missed On Wall Street On Wednesday

+26

Jan 21, 4:11 PM

Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan's

+26

Jan 21, 12:02 PM

Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin

LXRX

Jan 21, 8:38 AM

Charts

Today

Lexicon management to meet with Cantor

LXRX

4:25 PM

Lexicon management to meet with Cantor

LXRX

4:09 PM

Over a week ago

Midday Fly By: Nvidia boosts buyback, Boeing discovers 737 Max glitch

+27

Sep 28, 11:59 AM

Lexicon initiated with bullish view at Cantor Fitzgerald, here's why

LXRX

Sep 28, 8:04 AM

Lexicon initiated with bullish view at Cantor Fitzgerald

LXRX

Sep 28, 6:29 AM

Lexicon announces results from post hoc analysis of SOLOIST-WHF trial

LXRX

Aug 31, 8:53 AM

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Aug 24, 8:44 AM

Lexicon registers to sell 1.26M shares of common stock for holders

LXRX

Aug 6, 5:09 PM

Lexicon reports Q2 EPS (7c), consensus (5c)

LXRX

Aug 6, 9:03 AM

Lexicon completes enrollment in SONATA-HCM study

LXRX

Jul 27, 9:12 AM

Lexicon price target raised by 80c at Citi

LXRX

May 11, 6:46 AM

Lexicon reports Q1 EPS 0c, consensus (4c)

LXRX

May 7, 9:19 AM

Lexicon to present data at AAN annual meeting on Progress Phase 2b study

LXRX

Apr 17, 8:15 AM

Lexicon COGT reports Q1 EPS $2.07, consensus $1.74

LXRX

Apr 17, 8:07 AM

Lexicon, Novo Nordisk announce initiation of LX9851 study

Mar 23, 7:40 AM

Lexicon announces results from post hoc analysis on data of sotagliflozin

LXRX

Mar 11, 8:12 AM

Lexicon price target raised by 20c at Citi

LXRX

Mar 10, 6:46 AM

Lexicon price target raised by $2 at H.C. Wainwright, here's why

LXRX

Mar 5, 11:02 AM

Lexicon reports Q4 EPS (4c), consensus (7c)

LXRX

Mar 5, 7:04 AM

Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat

+27

Jan 30, 11:57 AM

Lexicon 32M share Spot Secondary priced at $1.30

LXRX

Jan 30, 6:04 AM

Lexicon announces common stock offering, no amount given

LXRX

Jan 29, 4:32 PM

What You Missed On Wall Street On Wednesday

+26

Jan 21, 4:11 PM

Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan's

+26

Jan 21, 12:02 PM

Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin

LXRX

Jan 21, 8:38 AM

Company News

Charts